O-0028 Adjuvant Folfox4 +/- Cetuximab in KRAS Wild-Type Patients with Resected Stage III Colon Cancer Results from the Petacc8 Intergroup Trial
Year: 2012
Type: conference-abstract
Source: Annals of Oncology
Authors: Julien Taieb, Josep Tabernero, Enrico Mini, Fabien Subtil, Gunnar Folprecht, Jean-Luc Van Laethem, Josef Thaler, John Bridgewater, Evaristo Sanches, Lone Nørgård Petersen, Philippe Rougier, Laurence Collette, Michel Praet, Cécile Girault, Martina Schneider, Pierre Squifflet, Pierre Laurent-Puig, Eric Van Cutsem, Laurent Bedenne, Come Lepage
Institutions: Hôpital Européen Georges-Pompidou, Vall d'Hebron Hospital Universitari, University of Florence, Fédération Francophone de Cancérologie Digestive, University Hospital Carl Gustav Carus, Erasmus Hospital, Barmherzige Schwestern vom heiligen Kreuz, University College London, IPO Porto, University of Copenhagen, European Organisation for Research and Treatment of Cancer, European Organisation for Research and Treatment of Cancer, International Drug Development Institute (Belgium), Université Paris Descartes, Universitair Ziekenhuis Leuven, CHU Dijon Bourgogne
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2999311024